Position in AMPH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$511,300
+$14,988 QoQ
Shares Held
25,337
+0.0% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#88
of 209 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMPH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ADVISORY RESEARCH INC holds $1,431,360 across 2 Drug Manufacturers - Specialty & Generic names. AMPH ranks #2 (35.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
19,782 | $920,060 | |
| 2 | AMPH |
Amphastar Pharmaceuticals, Inc.
This page
|
25,337 | $511,300 |
All Filings in AMPH
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $511,300 | 25,337 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $496,312 | 25,335 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $406,011 | 15,161 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $412,222 | 15,468 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $342,058 | 14,898 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $402,642 | 13,889 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $514,361 | 13,853 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $670,199 | 13,810 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $570,800 | 14,270 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $585,276 | 13,329 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $876,661 | 14,174 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $684,791 | 14,890 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $885,440 | 15,407 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $554,212 | 14,779 | Shares | Sole | 2023-05-12 | |
| 2022-09-30 | $425,658 | 15,148 | Shares | Sole | 2022-11-15 | |
| No filing history on record for this holder in this stock. | ||||||